ATP1A3+ EVs isolated from plasma from individualswith Alzheimer's disease demonstrated amyloid-β positivity,providing superior diagnostic accuracy compared to conventional plasmabiomarkers. This evidence concerns the gene ATP1A3 and Alzheimer disease.